Jack Jiagang Zhao

Jack Jiagang Zhao, PhD is the Co-Founder, Director, and CTO at SightStream Biotherapeutics. Prior to this, Jack was the Founder and CEO at Alpine BioTherapeutics Corp, where he developed ocular cell therapy products targeting inherited retinal diseases. Jack has a background in ocular stem cell research and application from his time at Shiley Eye Institute, University of California San Diego. With experience as a Founder at Alpine Biotech LLC and Faculty Investigator at Moores Cancer Center, Jack has made significant contributions to the field of biotechnology and drug discovery. His expertise in GPCR-focused drug discovery and molecular biology has led to the development of innovative approaches for classification of tumors. Throughout his career, Jack has demonstrated a commitment to advancing biomedical technologies and bringing cutting-edge therapies to market.